Sep 22, 2026 06:01AM
Sep 22, 2026 06:00AM
Sep 15, 2026 06:01AM
Sep 15, 2026 06:00AM
Sep 13, 2026 07:47PM
Sep 13, 2026 07:00AM
Aug 25, 2026 06:39PM Akeso's ivonescimab beats durvalumab in biliary tract cancer trial
Aug 25, 2026 06:00PM
Aug 25, 2026 07:02AM
Aug 25, 2026 07:00AM
Aug 12, 2026 09:22AM
Aug 12, 2026 09:22AM
Aug 5, 2026 07:00AM
Jul 24, 2026 07:51AM Summit Therapeutics plc (SMMT) PT Lowered to $38 at Guggenheim
Jul 23, 2026 04:06PM
Jul 23, 2026 04:05PM
Jul 22, 2026 04:30PM
Jul 22, 2026 04:30PM
Jul 22, 2026 06:30AM
Jul 22, 2026 06:30AM
Jul 16, 2026 08:00AM Summit Therapeutics to Host Second Quarter 2026 Financial Results & Operational Progress Call on July 23, 2026
Jul 14, 2026 07:00AM
Jul 14, 2026 07:00AM
Jun 9, 2026 04:47PM
Jun 9, 2026 04:47PM
Jun 4, 2026 04:30PM
Jun 1, 2026 02:53AM
May 31, 2026 09:06AM Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMON
May 30, 2026 08:00AM
May 14, 2026 09:15AM
May 4, 2026 07:32AM
Apr 30, 2026 04:32PM
Mar 27, 2026 08:16AM
Mar 27, 2026 08:15AM
Mar 16, 2026 12:50AM Jefferies Downgrades Summit Therapeutics plc (SMMT) to Hold
Feb 26, 2026 06:45PM
Feb 25, 2026 06:38AM
Feb 23, 2026 04:05PM
Feb 17, 2026 05:05PM
Feb 2, 2026 06:50AM
Jan 30, 2026 04:30PM
Jan 30, 2026 05:41AM Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens
Jan 29, 2026 07:30AM
Jan 29, 2026 07:30AM
Jan 12, 2026 06:15AM
Jan 12, 2026 06:15AM
Jan 12, 2026 06:01AM
Jan 12, 2026 06:00AM
Jan 9, 2026 08:16PM Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 6, 2026 07:30AM

331,677 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All